心脏代谢性心力衰竭:从分子特征到个性化治疗
Era Gorica1,2, Martin A Geiger3, Ludovica Di Venanzio3
1Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, Zurich University Hospital, University of Zurich, Wagistrasse 12, 8952, Schlieren, Switzerland. era.gorica@usz.ch.
Cardiovascular diabetology
|July 3, 2025
概括
保存喷射分数的心脏代谢性心力衰竭 (cmHFpEF) 源于代谢和血液动力压力,导致心脏功能障碍. 了解它的分子基础为这种不断增长的疾病提供了新的治疗点.
科学领域:
- 心脏病学 心脏病学
- 代谢性疾病 代谢性疾病
- 病理生理学 病理生理学
背景情况:
- 在全球范围内,心力衰竭与保留喷射分数 (HFpEF) 占所有心力衰竭病例的近一半.
- 心脏代谢性疾病的增加增加了心脏代谢性HFpEF (cmHFpEF) 现型的流行率.
- cmHFpEF是由于代谢压力,血液动力压力,免疫激活和全身炎症的融合而产生的.
研究的目的:
- 审查cmHFpEF的生物学和病理生理学的最新进展.
- 要突出包括代谢变化,免疫变化,微血管功能障碍,炎症和染色质重塑在内的关键方面.
- 讨论cmHFpEF潜在的基于机制的治疗策略.
主要方法:
- 关于cmHFpEF的最新科学研究的文献综述.
- 分子线索和病理生理机制的分析.
- 综合当前的理解和治疗方法.
主要成果:
- 在cmHFpEF之前有一个"代谢性心肌病",其特征是心肌代谢重塑和炎症.
- 这会导致左心室缩,扩张功能障碍和心房扩张.
- 最近的研究已经确定了cmHFpEF病变发生的分子基础.
结论:
- cmHFpEF是一个复杂的综合征,由多个相互关联的因素驱动.
- 了解分子和病理生理学环境对于开发有效的治疗方法至关重要.
- 针对涉及代谢变化,炎症和心脏重塑的特定途径具有治疗前景.
相关概念视频
Heart Failure V: Medical Management
29
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
29
Cardiomyopathy V: Interprofessional Care
38
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
38
Heart Failure IV: Classification and Diagnostic Evaluation
38
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
38
Pathophysiology of Heart Failure
1.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.9K
Cardiomyopathy II: Dilated Cardiomyopathy
30
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
30
Heart Failure II: Pathophysiology
51
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
51


